TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Stockholm Vaccin-Lättakut AB
Closing information (x1000 EUR)
| Closing information | 2024/04 | 2023/04 | 2022/04 |
| Turnover |
371
|
395
|
336 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-54
|
-28
|
-32 |
| EBITDA |
-54
|
-28
|
-32 |
| Total assets |
93
|
175
|
200 |
| Current assets |
92
|
173
|
198 |
| Current liabilities |
32
|
55
|
39 |
| Equity capital |
61
|
119
|
162 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
3
|
3
|
3 |
Financial ratios
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Solvency |
65.6%
|
68.0%
|
81.0% |
| Turnover per employee |
124
|
132
|
112 |
| Profit as a percentage of turnover |
-14.6%
|
-7.1%
|
-9.5% |
| Return on assets (ROA) |
-58.1%
|
-16.0%
|
-16.0% |
| Current ratio |
287.5%
|
314.5%
|
507.7% |
| Return on equity (ROE) |
-88.5%
|
-23.5%
|
-19.8% |
| Change turnover |
-9
|
89
|
-48 |
| Change turnover % |
-2%
|
29%
|
-13% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.